Insider · CIK 0002035970
Roy Gonzales
officer
Files at VTYX (Ventyx Biosciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Common Stock | -5,313 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -109,200 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -37,500 | - | - | 0 | Mar 4, 2026 |
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,000 | - | - | 0 | Mar 4, 2026 |
| Nov 17, 2025 | VTYX Ventyx Biosciences, Inc. | AGrant or award Common Stock | +1,767 | $1.03 | $1,820 | 5,313 | Nov 19, 2025 |
| May 15, 2025 | VTYX Ventyx Biosciences, Inc. | AGrant or award Common Stock | +1,750 | $1.03 | $1,803 | 3,546 | May 16, 2025 |
| Jan 2, 2025 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +109,200 | $0.00 | $0 | 109,200 | Jan 3, 2025 |
| Jan 2, 2025 | VTYX Ventyx Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.